OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study.

C DomínguezP Pozo-RosichMarta Torres-FerrúsN Hernández-BeltránC Jurado-CoboC González-OriaS SantosM J MonzónG LatorreL C ÁlvaroA GagoM GallegoV MedranoM HuertaJ García-AlhamaR BelvísHana ChoR Leira

Published in: European journal of neurology (2017)

This study confirmed the effectiveness of treatment with OnabotulinumtoxinA after 1 year of treatment. The chances of a good outcome may be increased by starting treatment in the first 12 months after chronic migraine diagnosis.

Keyphrases

randomized controlled trial
systematic review
replacement therapy
smoking cessation